These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 31705658)
1. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling. Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658 [TBL] [Abstract][Full Text] [Related]
2. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells. Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668 [TBL] [Abstract][Full Text] [Related]
3. A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction. Bisson SA; Page AL; Ganem D J Virol; 2009 May; 83(10):5056-66. PubMed ID: 19279093 [TBL] [Abstract][Full Text] [Related]
4. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes. Zaritsky LA; Bedsaul JR; Zoon KC J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085 [TBL] [Abstract][Full Text] [Related]
5. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription. Komatsu T; Takeuchi K; Yokoo J; Tanaka Y; Gotoh B J Virol; 2000 Mar; 74(5):2477-80. PubMed ID: 10666284 [TBL] [Abstract][Full Text] [Related]
7. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation. Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454 [TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity. Yuan H; You J; You H; Zheng C J Virol; 2018 Oct; 92(19):. PubMed ID: 29997210 [TBL] [Abstract][Full Text] [Related]
9. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance. Shang D; Liu Y; Ito N; Kamoto T; Ogawa O Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897 [TBL] [Abstract][Full Text] [Related]
10. 6-Hydroxy-3-O-methyl-kaempferol 6-O-glucopyranoside potentiates the anti-proliferative effect of interferon α/β by promoting activation of the JAK/STAT signaling by inhibiting SOCS3 in hepatocellular carcinoma cells. Wonganan O; He YJ; Shen XF; Wongkrajang K; Suksamrarn A; Zhang GL; Wang F Toxicol Appl Pharmacol; 2017 Dec; 336():31-39. PubMed ID: 29031523 [TBL] [Abstract][Full Text] [Related]
11. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. Lin RJ; Chang BL; Yu HP; Liao CL; Lin YL J Virol; 2006 Jun; 80(12):5908-18. PubMed ID: 16731929 [TBL] [Abstract][Full Text] [Related]
12. Kinase-deficient forms of Jak1 and Tyk2 inhibit interferon alpha signaling in a dominant manner. Krishnan K; Pine R; Krolewski JJ Eur J Biochem; 1997 Jul; 247(1):298-305. PubMed ID: 9249040 [TBL] [Abstract][Full Text] [Related]
13. TRIM10 binds to IFN-α/β receptor 1 to negatively regulate type I IFN signal transduction. Guo M; Cao W; Chen S; Tian R; Wang L; Liu Q; Zhang L; Wang Z; Zhao M; Lu Q; Zhu H Eur J Immunol; 2021 Jul; 51(7):1762-1773. PubMed ID: 33811647 [TBL] [Abstract][Full Text] [Related]
14. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853 [TBL] [Abstract][Full Text] [Related]
15. Synthetic Heterodimers of Type III Interferon Receptors Require TYK2 for STAT Activation. Mesev EV; Guare EG; Ploss A; Toettcher JE J Interferon Cytokine Res; 2023 Sep; 43(9):414-426. PubMed ID: 37725008 [TBL] [Abstract][Full Text] [Related]
16. A novel viral SOCS from infectious spleen and kidney necrosis virus: interacts with Jak1 and inhibits IFN-α induced Stat1/3 activation. Guo CJ; Yang LS; Zhang YF; Wu YY; Weng SP; Yu XQ; He JG PLoS One; 2012; 7(7):e41092. PubMed ID: 22844427 [TBL] [Abstract][Full Text] [Related]
17. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs. Shemesh M; Lochte S; Piehler J; Schreiber G Sci Signal; 2021 Nov; 14(710):eabe4627. PubMed ID: 34813358 [TBL] [Abstract][Full Text] [Related]
18. Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling. Odkhuu E; Komatsu T; Naiki Y; Koide N; Yokochi T Int Immunopharmacol; 2014 Nov; 23(1):267-72. PubMed ID: 25242386 [TBL] [Abstract][Full Text] [Related]
19. Impaired type I IFN-induced Jak/STAT signaling in FA-C cells and abnormal CD4+ Th cell subsets in Fancc-/- mice. Fagerlie SR; Koretsky T; Torok-Storb B; Bagby GC J Immunol; 2004 Sep; 173(6):3863-70. PubMed ID: 15356134 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. Best SM; Morris KL; Shannon JG; Robertson SJ; Mitzel DN; Park GS; Boer E; Wolfinbarger JB; Bloom ME J Virol; 2005 Oct; 79(20):12828-39. PubMed ID: 16188985 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]